Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma

Steven M. Sorscher, Albert Craig Lockhart

Research output: Contribution to journalLetterpeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)2735-2736
Number of pages2
JournalJournal of Clinical Oncology
Issue number19
StatePublished - Jul 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this